-
February 2, 2012
UK says home-grown cancer pill too costly to use
LONDON (Reuters) - Britain's health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country's top cancer research center, a decision critics said was bad for patients and research.
-
February 1, 2012
CORRECTION: Seed therapy for prostate cancer may zap fertility
NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.
-
February 1, 2012
Seed therapy for prostate cancer may zap fertility
NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.
-
January 30, 2012
Pricey surgery robots lack clear benefits: study
NEW YORK (Reuters Health) - As robots march into operating rooms across the nation, some doctors are getting worried that patients might not be better off with the costly machines.
-
January 26, 2012
REFILE: Men's hopes for robot prostate surgery unrealistic
NEW YORK (Reuters Health) - Robot-assisted surgery for prostate cancer has been heavily hyped, and a new study suggests that men's expectations of the surgery may be too high.
-
January 25, 2012
Men's hopes for robot prostate surgery unrealistic
NEW YORK (Reuters Health) - Robot-assisted surgery for prostate cancer has been heavily hyped, and a new study suggests that men's expectations of the surgery may be too high.
-
January 10, 2012
New DNA reader to bring genetics to clinics
NEW YORK (Reuters) - A new DNA reader could bring genetics to medical clinics.
-
January 6, 2012
Don't believe hype about robot prostatectomy: study
NEW YORK (Reuters Health) - Older men considering robotic surgery for prostate cancer shouldn't trust the rosy ads promoting the expensive technology over low-tech surgery.
-
January 6, 2012
PSA screening doesn't prevent cancer deaths: study
NEW YORK (Reuters Health) - Annual screening for prostate cancer doesn't cut men's chances of dying from the disease, according to the latest results of a large screening trial.
-
December 29, 2011
Milk intake in teens tied to later prostate cancer
NEW YORK (Reuters Health) - Older Icelandic men who remember chugging a lot of milk in their teens are three times as likely to be diagnosed with advanced prostate cancer as more-moderate milk drinkers, researchers have found.
-
December 29, 2011
Statins tied to lower risk of fatal prostate cancer
NEW YORK (Reuters Health) - In a new study of middle-aged New Jersey men, taking cholesterol-lowering drugs was linked to a lower chance of dying from prostate cancer.
-
December 19, 2011
Health panel takes heat on cancer screening advice
WASHINGTON (Reuters) - Dr. Ned Calonge knows firsthand how hard it is to tell Americans they'd be better off with fewer routine medical tests.
-
December 14, 2011
Cancer group aims to boost trust in guidelines
NEW YORK (Reuters Health) - In a field plagued by frequent controversy, the American Cancer Society has taken "a major step forward" with a new system for developing trustworthy screening recommendations.
-
December 12, 2011
Many elderly screened for cancer despite doubts
NEW YORK (Reuters Health) - Although the benefits of cancer screening in elderly people are often less certain than the risks, many silver-haired Americans are still getting the routine tests, researchers said Monday.
-
December 8, 2011
Heart disease tied to regret after prostate therapy
NEW YORK (Reuters Health) - Men with heart problems are more likely to regret prostate cancer treatment than others, according to a recent study.
-
December 7, 2011
Some men can delay prostate cancer treatment-panel
CHICAGO (Reuters) - Men with low-risk prostate cancer may wait to see if their disease progresses before treating it, an independent panel of experts convened by the U.S. National Institutes of Health (NIH) said on Wednesday.
-
December 6, 2011
Prostate cancer hormonal therapy cuts deaths: report
NEW YORK (Reuters Health) - For men with aggressive prostate cancer, hormone-targeted therapy cuts the overall risk of death, according to a new review of past studies.
-
December 1, 2011
Hormonal prostate cancer therapy tied to blood clots
NEW YORK (Reuters Health) - Hormone-targeted therapy for prostate cancer may raise the risk of potentially dangerous blood clots, a large U.S. study suggests.
-
December 1, 2011
Americans mixed on adequacy of cancer screenings
-
November 21, 2011
Medicare to cover Provenge infusion costs: Dendreon
-
October 25, 2011
Mammograms don't save as many lives as women think
CHICAGO (Reuters) - Many women who have survived breast cancer often say it was a mammogram that "saved their life," a powerful testimonial that can encourage other women to get regular breast cancer screening tests.
-
October 19, 2011
US health panel cautious on HPV screening vs Pap
WASHINGTON (Reuters) - A U.S. government-backed medical panel on Wednesday took a cautious view of a new generation of cervical cancer tests, discouraging women under the age of 30 to screen for human papillomavirus as a way to prevent cancer.
-
October 13, 2011
Infections after prostate biopsy on the rise
NEW YORK (Reuters Health) - Serious infections after prostate biopsies appear to be on the rise in the U.S., possibly fueled by antibiotic-resistant bacteria, a new study of elderly men suggests.
-
October 11, 2011
Vitamin E tied to higher risk of prostate cancer
NEW YORK (Reuters Health) - Men taking daily vitamin E were more likely to get prostate cancer than those not taking the dietary supplement in a new study of close to 35,000 North Americans.
-
October 11, 2011
Prostate surgery risks greater for elderly men
NEW YORK (Reuters Health) - Elderly men who have prostate cancer surgery face heightened risks of complications -- and the majority have the procedure at hospitals with less-than-optimal outcomes, a U.S. study suggests.
-
October 7, 2011
PSA test for prostate cancer not recommended-US panel
CHICAGO (Reuters) - A U.S. government-backed panel recommended against routine prostate cancer screening on Friday because widespread screening for the disease causes more harm than good.
-
October 7, 2011
Groups defend need for prostate screening
CHICAGO (Reuters) - Reports that an influential group of advisers plans to recommend against routine screening of prostate cancer have drawn criticism from health groups worried the move will increase cancer deaths in men.
-
October 6, 2011
Nobel winner's last big experiment: Himself
CHICAGO/NEW YORK (Reuters) In the last few years of his life, Dr. Ralph Steinman made himself into an extraordinary human lab experiment, testing a series of unproven therapies - including some he helped to create - as he waged a very personal battle with pancreatic cancer.
-
October 4, 2011
Higher testosterone tied to lower heart risks
NEW YORK (Reuters Health) - Elderly men with naturally higher levels of testosterone may be less likely to suffer a heart attack or stroke than those with lower levels of the hormone, a new study finds.
-
October 3, 2011
Nobelist who died before announcement to keep prize
LONDON/CHICAGO (Reuters) - Ralph Steinman proved the importance of his Nobel prize-winning research in a most personal way, using his own discoveries to fight the pancreatic cancer that eventually killed him just days before the award was announced.
-
October 3, 2011
Nobel prizewinner dies before announcement
STOCKHOLM (Reuters) - A scientist who won the Nobel prize for medicine on Monday for work on fighting cancer died of the disease himself just three days before he could be told of his award, and after using his own discoveries to extend his life.
-
October 3, 2011
Nobel medicine prize honours work on body's defences
STOCKHOLM (Reuters) - Three scientists who unlocked secrets of the body's immune system, opening doors to new vaccines and cancer treatments, won the 2011 Nobel prize for medicine on Monday.
-
September 26, 2011
REFILE: Americans get too much healthcare, their docs say
NEW YORK (Reuters Health) - Here is a diagnosis of what's wrong with health care in America, straight from the horse's mouth: There's too much.
-
September 26, 2011
Roche bone drug eases pain in prostate cancer trial
STOCKHOLM (Reuters) - Roche's bone strengthening drug Boniva is as good for pain relief as single dose radiotherapy in patients whose prostate cancer has spread to their bones, according to data from a late-stage trial released on Sunday.
-
September 26, 2011
Cancer cost "becoming unsustainable" in rich nations
STOCKHOLM (Reuters) - An explosion of new technologies and treatments for cancer coupled with a rapid rise in cases of the disease worldwide mean cancer care is rapidly becoming unaffordable in many developed countries, oncology experts said on Monday.
-
September 21, 2011
Private insurance, better prostate surgery outcome?
NEW YORK (Reuters Health) - U.S. men who have surgery for prostate cancer seem to fare better if they have private insurance rather than public coverage through Medicare or Medicaid, a new study finds.
-
September 20, 2011
CORRECTION: Doctors predict impotence after prostate treatment
NEW YORK (Reuters Health) - A man facing prostate cancer treatment can now get a rough sense of his odds of becoming impotent after the procedure, researchers said Tuesday.
-
September 7, 2011
J&J's prostate cancer drug approved in EU
LONDON (Reuters) - Johnson & Johnson's prostate cancer drug Zytiga has been approved in the European Union, paving the way for the launch of a new treatment for men whose disease has progressed after chemotherapy, the company said on Wednesday.
-
September 6, 2011
Zimbabwe's Mugabe has prostate cancer: WikiLeaks
JOHANNESBURG (Reuters) - Zimbabwean President Robert Mugabe has prostate cancer that has spread to other organs and was urged by his physician to step down in 2008, according to a U.S. diplomatic cable released by WikiLeaks.
-
August 29, 2011
Lockerbie bomber "at death's door" in Libya: report
WASHINGTON (Reuters) - The Libyan convicted in the 1988 bombing of a U.S.-bound airliner over Lockerbie, Scotland has been found in Tripoli and appears "at death's door," CNN reported on Sunday.
-
August 26, 2011
Doctors misuse scans in prostate cancer: study
NEW YORK (Reuters Health) - Too many men with low- or medium-risk prostate cancer get CTs and bone scans that aren't recommended for them, suggests a new study.
-
August 22, 2011
Seattle Genetics cancer drug price may top $100,000
WASHINGTON (Reuters) - The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost.
-
August 17, 2011
REFILE: FDA approves Roche skin cancer drug Zelboraf
WASHINGTON (Reuters) - U.S. drug regulators on Wednesday approved a targeted skin cancer drug from Roche Holding along with its diagnostic test, an advance in personalized health care.
-
August 9, 2011
REFILE: US approval of Roche melanoma drug may come early
LOS ANGELES (Reuters) - U.S. regulators are moving quickly with Roche's application for targeted melanoma drug vemurafenib, which could receive approval as early as this week, according to a source familiar with the situation.
-
August 9, 2011
US approval of Roche melanoma drug may come early
LOS ANGELES (Reuters) - U.S. regulators are moving quickly with Roche's application for targeted melanoma drug vemurafenib, which could receive approval as early as this week, according to a source familiar with the situation.
-
August 5, 2011
Peer feedback cuts doctors' over-use of tests
NEW YORK (Reuters Health) - Feedback from fellow physicians helped doctors do fewer unnecessary tests on newly diagnosed prostate cancer patients in a study aimed at improving health care quality and consistency.
-
August 4, 2011
After prostate surgery, some men leak during sex
NEW YORK (Reuters Health) - Incontinence during sex is a long-lasting problem for roughly one in eight men who've had their prostate removed due to cancer, a study of more than 1,400 patients has found.
-
July 20, 2011
Cancer-stricken Chavez softens on prisoners
CARACAS (Reuters) - Venezuelan President Hugo Chavez, humbled by a cancer that has upended the OPEC nation's politics, has set clemency proceedings in motion for convicted opposition activists suffering from health problems.
-
July 20, 2011
Study finds no statin, cancer link
NEW YORK (Reuters Health) - People on cholesterol-lowering statins appear to be no more likely to develop cancer than non-users, a new study concludes -- adding to evidence that contradicts a widely publicized report of raised cancer risk from the popular medications.
-
July 19, 2011
Do robots drive up prostate surgeries?
NEW YORK (Reuters Health) - After Wisconsin hospitals acquired robotic surgery technology, the number of prostate removals they performed doubled within three months, a new study shows.